UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

British journal of clinical pharmacology, 2003-07, Vol.56 (1), p.32-38

2003

Volltextzugriff (PDF)

Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations

PloS one, 2013-07, Vol.8 (7), p.e67946

2013

Volltextzugriff (PDF)

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

PloS one, 2011-12, Vol.6 (12), p.e27810

2011

Volltextzugriff (PDF)

Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.676-684

2010

Volltextzugriff (PDF)

Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

Clinical pharmacology and therapeutics, 2011-09, Vol.90 (3), p.406-413

2011

Volltextzugriff (PDF)

Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania

PloS one, 2012-07, Vol.7 (7), p.e40180

2012

Volltextzugriff (PDF)

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3311-3319

2014

Volltextzugriff (PDF)

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

The pharmacogenomics journal, 2013-12, Vol.13 (6), p.484-489

2013

Volltextzugriff (PDF)

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

Clinical pharmacology and therapeutics, 2005-07, Vol.78 (1), p.25-33

2005

Volltextzugriff (PDF)

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2350-2361

2011

Volltextzugriff (PDF)

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

Clinical pharmacology and therapeutics, 2004-07, Vol.76 (1), p.73-84

2004

Volltextzugriff (PDF)

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40

Clinical pharmacology and therapeutics, 2003-05, Vol.73 (5), p.397-405

2003

Volltextzugriff (PDF)

Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria

European journal of clinical pharmacology, 2004-12, Vol.60 (10), p.709-715

2004

Volltextzugriff (PDF)

Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg

Nephrology, dialysis, transplantation, 2006-04, Vol.21 (4), p.1019-1023

2006

Volltextzugriff (PDF)

Oat gum lowers glucose and insulin after an oral glucose load

The American journal of clinical nutrition, 1991-06, Vol.53 (6), p.1425-1430

1991

Volltextzugriff (PDF)

Undeclared exposure to St. John's Wort in hospitalized patients

British journal of clinical pharmacology, 2004-10, Vol.58 (4), p.437-441

2004

Volltextzugriff (PDF)

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]

Malaria journal, 2005-09, Vol.4 (1), p.45-45, Article 45

2005

Volltextzugriff (PDF)

Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load

British journal of nutrition, 1994-11, Vol.72 (5), p.731-743

1994

Volltextzugriff (PDF)

In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6

Naunyn-Schmiedeberg's archives of pharmacology, 2008-09, Vol.378 (3), p.275-282

2008

Volltextzugriff (PDF)

Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-12, Vol.813 (1), p.27-33

2004

Volltextzugriff (PDF)

Fluvoxamine affects sildenafil kinetics and dynamics

Journal of clinical psychopharmacology, 2005-12, Vol.25 (6), p.589-592

2005

Volltextzugriff (PDF)

Poor solubility limiting significance of in-vitro studies with HIV protease inhibitors

AIDS (London), 2002-03, Vol.16 (4), p.674-676

2002

Volltextzugriff (PDF)

Highly sensitive determination of saquinavir in biological samples using liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-02, Vol.784 (2), p.233-242

2003

Volltextzugriff (PDF)

Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid

International journal of clinical pharmacology and therapeutics, 2007-08, Vol.45 (8), p.431-437

2007

Volltextzugriff (PDF)

High β-Glucan Oat Bran and Oat Gum Reduce Postprandial Blood Glucose and Insulin in Subjects With and Without Type 2 Diabetes

Diabetic medicine, 1994-04, Vol.11 (3), p.312-318

1994

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(161)

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Computer Science
(123)
Engineering
(123)
Engineering, Manufacturing
(123)
Technology
(123)
Computer Science, Information Systems
(121)
Life Sciences & Biomedicine
(33)
Humans
(32)
Industrie 4.0
(27)
Biological And Medical Sciences
(23)
Male
(23)
Industry 4.0
(22)
Medical Sciences
(21)
Adult
(20)
Female
(19)
Pharmacology & Pharmacy
(19)
Pharmacology. Drug Treatments
(19)
Fallstudie
(15)
Produktionssystem
(13)
Instandhaltung
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients

Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40

Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria

Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg

Oat gum lowers glucose and insulin after an oral glucose load

Undeclared exposure to St. John's Wort in hospitalized patients

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]

Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load

In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6

Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography–tandem mass spectrometry

Fluvoxamine affects sildenafil kinetics and dynamics

Poor solubility limiting significance of in-vitro studies with HIV protease inhibitors

Highly sensitive determination of saquinavir in biological samples using liquid chromatography–tandem mass spectrometry

Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid

High β-Glucan Oat Bran and Oat Gum Reduce Postprandial Blood Glucose and Insulin in Subjects With and Without Type 2 Diabetes

Suchergebnisse filtern